Insurance Coverage and Access Requirements for Lower-Emission Inhalers in US Commercial Health Plans

• by Ashwaghosha Parthasarathi, Paras Modha, Adithi Chellappan, Chloe Kline, Reynold A. Panettieri, Soko Setoguchi

• September 28, 2026

VA/DoD guideline broadens tobacco treatment

Recommendations prioritize varenicline and combination NRT while extending pharmacotherapy to patients not ready to quit.

• by Andrea Surnit

• September 28, 2026

• 5 min

Intravenous-to-enteral drug substitution in the ICU: a single-centre analysis of the potential to reduce the environmental footprint of critical care

• by Clémence Marois, Maxime Gasperment, Adam Celier, Ambre Preteux, Grégoire Gaucher, Léontine Scherer, Nicolas Weiss, Kevin Bihan, Marie Lecronier, Amélie Liou

• September 22, 2026

Comment on: Changes in microbiological characteristics of bloodstream infections before and after the COVID-19 pandemic in a tertiary teaching hospital in Iran

• by Sebastiana Silva Sabino, Alexia Máximo Fernandes, Natália Ludendorff Queiroz, Cristiane Silveira de Brito, Lícia Ludendorff Queiroz, Celsa Raquel Villaverde Melgarejo, Paulo P. Gontijo Filho, Rosineide Marques Ribas

• September 16, 2026